{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T18:26:57Z","timestamp":1696357617565},"reference-count":26,"publisher":"Hindawi Limited","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2100,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1111\/j.1600-0404.2009.01269.x","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T01:42:45Z","timestamp":1260495765000},"page":"no-no","source":"Crossref","is-referenced-by-count":3,"title":["Validation of Serbian version of the disease-specific myasthenia gravis questionnaire"],"prefix":"10.1155","author":[{"given":"I.","family":"Basta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Pekmezovi\u00c4\u0087","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Padua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Stojanovi\u00c4\u0087","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Stevi\u00c4\u0087","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nikoli\u00c4\u0087","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Peri\u00c4\u0087","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lavrni\u00c4\u0087","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB1|cit2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","article-title":"Less is more, or almost as much: a 15-item quality of life instrument for myasthenia gravis","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB2|cit3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s100720100066","article-title":"Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements","volume":"22","author":"Padua","year":"2001","journal-title":"Neurol Sci"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB3|cit4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s100720200027","article-title":"Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire","volume":"23","author":"Padua","year":"2002","journal-title":"Neurol Sci"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB4|cit5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10072-004-0366-5","article-title":"Myasthenia gravis self-administered questionnaire: development of regional domains","volume":"25","author":"Padua","year":"2005","journal-title":"Neurol Sci"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB5|cit6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21016","article-title":"Disease-specific measure of quality of life for myasthenia gravis","volume":"38","author":"Mullins","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB6|cit7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/01.wnl.0000257819.47628.41","article-title":"Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL)","volume":"68","author":"Vincent","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB7|cit8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards","volume":"55","author":"Jeretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB8|cit9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10072-006-0606-y","article-title":"Validation of the Swedish version of the disease-specific myasthenia gravis questionnaire","volume":"27","author":"Rostedt","year":"2006","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1111\/j.1600-0404.2009.01269.x-BIB9|cit10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1468-1331.2006.01149.x","article-title":"Correlation between regional myasthenic weakness and mental aspects of quality of life","volume":"13","author":"Rostedt","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB10|cit11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0404.1999.tb00733.x","article-title":"Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983\u00e2\u0080\u00931992)","volume":"100","author":"Lavrni\u00c4\u0087","year":"1999","journal-title":"Acta Neurol Scan"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB11|cit12","first-page":"2001","article-title":"Familial occurrence of autoimmune myasthenia gravis with different antibody specificity","volume":"70","author":"Lavrni\u00c4\u0087","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB12|cit13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.2005.00378.x","article-title":"Cyclosporine in the treatment of myasthenia gravis","volume":"111","author":"Lavrni\u00c4\u0087","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB13|cit14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK","volume":"76","author":"Lavrni\u00c4\u0087","year":"2005","journal-title":"J Neurol Neurosurg Psychiat"},{"issue":"1","key":"10.1111\/j.1600-0404.2009.01269.x-BIB14|cit15","first-page":"152","article-title":"Distal myasthenia gravis","volume":"56","author":"Pavlovi\u00c4\u0087","year":"2007","journal-title":"Neurol Croat"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB15|cit16","first-page":"497","article-title":"Studies in myasthenia gravis: review of twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"Mount Sinai J Med"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB16|cit17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB17|cit18","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB18|cit19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/03009749509099285","article-title":"Cross-cultural adaptation and validation of health status measures","volume":"24","author":"Guillemin","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB19|cit20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.314.7080.572","article-title":"Cronbach\u00e2\u0080\u0099s alpha","volume":"317","author":"Bland","year":"1997","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB20|cit21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02288803","article-title":"Estimation of the reliability of ratings","volume":"16","author":"Ebel","year":"1951","journal-title":"Psychometrika"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB21|cit22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB22|cit23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.1034","article-title":"Quality of life and well-being of patients with myasthenia gravis","volume":"24","author":"Paul","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB23|cit24","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB24|cit25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1600-0404.2009.01269.x-BIB25|cit26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1474-4422(07)70290-9","article-title":"Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations","volume":"6","author":"Hobart","year":"2007","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1111\/j.1600-0404.2009.01269.x-BIB26|cit27","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.clinph.2005.05.017","article-title":"Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in myasthenia gravis patients","volume":"116","author":"Rostedt","year":"2005","journal-title":"Clin Neurophysiol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2009.01269.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2009.01269.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:47:54Z","timestamp":1671540474000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2009.01269.x"}},"subtitle":["Serbian myasthenia gravis questionnaire"],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":26,"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2009.01269.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}